Poseida TherapeuticsPSTX
13F holders, Q1 2025 (March 31)1holders −114
0new positions
112sold out
$3.08avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Poseida Therapeutics Inc. (PSTX) in their 13F filings, down 114 from Q4 2024. 0 opened new positions and 112 sold out. The largest holder was DekaBank Deutsche Girozentrale ($308K).
- Company
- Poseida Therapeutics Inc.
- CUSIP
- 73730P108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 112 | $514.3M |
All 13F filers, Q4 2024 → Q1 2025: 53,569,591 shares sold, net −53,569,591 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 100,000 | $308K |
"% of holder's portfolio" is PSTX's weight in each manager's 13F, not the share of Poseida Therapeutics Inc. the manager owns.